HEPATITIS DELTA

adds layers of risk for disease progression¹

Hepatitis D is the most severe, potentially underdiagnosed form of chronic viral hepatitis with no FDA-approved treatment.^1-3

See burden of disease

Hepatitis D is the most severe, potentially underdiagnosed form of chronic viral hepatitis with no FDA-approved treatment.^1-3

See burden of disease

Experts recommend screening hep B patients with certain key risk factors⁴

GUIDELINES FOR
TESTING & DIAGNOSIS

Up to
80%

Up to 80% of chronic hep D patients in the US develop cirrhosis and liver failure within 5‑10 years¹

UP TO
80%

of chronic hep D patients in the US develop cirrhosis and liver failure within 5-10 years¹

More about
Burden of Disease

Persons from endemic regions are the largest group at risk of hep delta⁵

SEE MAP OF
ENDEMIC AREAS

References: 1. Centers for Disease Control and Prevention. Hepatitis D questions and answers for health professionals. Updated March 9, 2020. Accessed August 9, 2021. https://www.cdc.gov/hepatitis/hdv/hdvfaq.htm 2. World Health Organization. Hepatitis D fact sheet. Updated July 28, 2021. Accessed August 9, 2021. https://www.who.int/news-room/fact-sheets/detail/hepatitis-d 3. Patel EU, Thio CL, Boon D, Thomas DL, Tobian AAR. Prevalence of hepatitis B and hepatitis D virus infections in the United States, 2011–2016. Clin Infect Dis. 2019;69(4):709-712. doi:10.1093/cid/ciz001 4. Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67:1560-1599. doi:10.1002/hep.29800 5. Toy M, Ahishalı E, Yurdaydın C. Hepatitis delta virus epidemiology in the industrialized world. AIDS Rev. 2020;22:203-212. doi:10.24875/AIDSRev.20000056